Introduction
Staphylococcus aureus is a bacterium commonly found on normal skin and in the nasal flora of healthy individuals in the community. It is estimated that at least 30% of the US population are permanently colonized or are transient carriers of S. aureus [1] [2] [3] . Since the development of antibiotics, S. aureus has quickly become resistant to many antibiotics that are commonly used to treat staphylococcal infections, such as beta-lactams and macrolides [1, 2, 4, 5] . Currently, methicillinresistant S. aureus (MRSA) infections are endemic in many healthcare institutions. Furthermore, new strains of MRSA are developing within communities, affecting people without recognized risk factors for hospital-acquired MRSA (HA-MRSA) [6] [7] [8] [9] [10] .
Background and significance
Beginning in the 1990s, community-acquired MRSA (CA-MRSA) infections emerged in persons without recognized risk factors associated with MRSA, such as a prior history of healthcare exposure, hospitalization, surgery, permanent intravenous lines and other indwelling devices, or hemodialysis [3, [10] [11] [12] [13] . Compared with the antibiotic-resistant nature of HA-MRSA, CA-MRSA is more susceptible to antibiotic treatment, and uncomplicated cases can be treated successfully in an ambulatory care setting [11] . The majority of infections caused by CA-MRSA are skin and soft tissue infections (SSTIs) that typically present as boils, abscesses, or cellulitis [10, [14] [15] [16] .
Patients present to primary care with lesions that are pustular and may have central necrosis or purulent drainage. The lesions may be reddened and demonstrate tender and palpable fluctuance. Healthcare providers commonly treat patients presenting with SSTIs with antibiotics used to treat methicillin-sensitive S. aureus (MSSA) [4, 5] . However, these antibiotics are not therapeutic for CA-MRSA, leading to treatment failure, increasing a patient's exposure to more antibiotics, allowing possible contact with drainage from lesions to more people in the community, and increasing the associated healthcare costs with repeated visits to the primary care office.
The purpose of this study was to determine if there is a relationship between the increased prevalence of SSTIs and CA-MRSA by comparing the occurrences in 1997-2002 and 2003-2008 and changes in prescribing patterns for antibiotics for patients presenting with SSTIs. We hypothesize that by identifying an increase in CA-MRSA within a population, practitioners will more likely screen for the presence of MRSA and treat with the appropriate antibiotics.
Review of the literature
CA-MRSA is described as a leading cause of SSTIs in the United States [10, 17] . Approximately 80% of CA-MRSA infections are SSTIs [10] . In addition, CA-MRSA infections have emerged among patient groups with risk factors not associated with healthcare, which includes patients with sports exposure, incarceration, intravenous drug use, overcrowded housing, and poor hygiene [11, 16, [18] [19] [20] . However, the epidemiology of CA-MRSA is becoming increasingly complex, and in primary care, patients found to be working in a healthcare setting are also at increased risk [21, 22] . Nonetheless, the prevalence of CA-MRSA is increasing, and notably, patients presenting with SSTIs are being treated without consideration of the drug-resistant nature of MRSA [23] .
Often, treatment of abscesses with incision and drainage is an adequate treatment for SSTIs caused by Staphylococcal infections [23] [24] [25] . Studies suggest that treatment of SSTIs after surgical drainage and treatment with prescription of antibiotics not effective against MRSA infections have high success rates [23, 25] . However, in an international survey conducted by the New England Journal of Medicine, the majority of the respondents indicated that antibiotic treatment would be prescribed following incision and drainage [26] .
Antibiotics classes commonly prescribed for MSSA infections are the beta-lactams and cephalosporins. However, they have no therapeutic effect on MRSA. If there is clinical suspicion of CA-MRSA in SSTIs and the patient is described as high risk, it is important to culture SSTIs and prescribe antibiotics based on culture and sensitivities of the sample [3, 17, 27] . Antibiotic classes shown to have therapeutic effects on MRSA are fluoroquinolones, tetracyclines, clindamycin, and trimethoprim/sulfamethoxazole [20, 23, 28] .
In an outpatient setting, trimethoprim/sulfamethoxazole, fluoroquinolones, tetracyclines, and clindamycin have demonstrated therapeutic effects on CA-MRSA with monotherapy [20, 23, 25, 28] . Linezolid is also a feasible treatment option for CA-MRSA; however, it is very expensive compared with other drugs with similar efficacies and should be reserved for the more resistant strains associated with HA-MRSA [14, 18, 27] . Rifampicin is not prescribed for monotherapy but is prescribed in combination with other antibiotics for active infections for a synergistic effect.
Methods
A secondary analysis of a publicly available dataset was used to examine occurrences of patients presenting with SSTIs and the antibiotics prescribed for treatment.
Data source
Public use data from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) were used for this analysis. The NAMCS is a probability sample survey of office-based physicians in the United States. The NHAMCS is an annual probability sample survey of hospital outpatient departments and emergency departments in the US. The US Census Bureau is responsible for field operations and data collection. Drugs are coded in terms of their generic components and therapeutic classes using Lexicon Plus. The Lexicon Plus is a comprehensive database of all prescription and nonprescription drugs available in the US market (http://www.multum.com/Lexicon.htm).
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Analysis
To estimate the number of visits in all ambulatory settings, NAMCS and NHAMCS data were combined to produce national estimates, and the data were separated into 2 groups of 5 years each (1997-2002 and 2003-2008) . The frequencies were calculated, as were the percentages of visits of selected ICD-9 codes, patient characteristics, and antibiotic drugs with 95% CI and standard error using the estimates of the US population provided by the US Census Bureau and with SAS statistical analysis software. To further determine which factors were independently associated with SSTIs, a logistic regression analysis of all visits was performed. The dependent variable was defined as a diagnosis of one of the SSTIs. The model contains the following independent variables: age, sex, race, ethnicity, and expected source of payment. Tables 1 and 2 , during 1997-2002, a total of 4.8 million visits were made to US ambulatory care providers for selected skin and soft tissue infections, which represents 0.6% (95% CI 0.59-0.68) of all visits. The incidence increased during 2003-2008: a total of 7.3 million visits were made to US ambulatory care providers for SSTS, representing 0.83% (95% CI 0.78-0.88) Tables 3a and 4a shows the visit frequency and percentage distributions for SSTIs according to the patient characteristics of sex, age, ethnic, race, and payment type. When comparing these two tables, the distributions of the characteristics for both periods reveal no significant differences in patient demographics. In the two periods, the factor of sex had no impact on the number and percentage distribution of visits. As for age, the frequency of visits in the two periods was higher for persons aged 25-64 than Tables 3b and 4b ).
Results
Based upon comparison of
Comparing the antibiotics prescribed in Tables 5 and 6 , the prescription of penicillins decreased by 21.2%, and cephalosporin prescriptions decreased by 24%. Both of these antibiotics are not effective against MRSA. Tetracycline prescriptions increased by 471%, quinolones/derivatives increased by 94%, and cephalosporins, which were once the first-line antibiotics prescribed for SSTIs. Demographics of age, sex, race, ethnicity, and pay type did not reveal any significant changes for patients presenting with SSTIs between the two time periods examined. The source of payment or pay type does not reflect on a patient's income or social status. However, due to the increasing cost of fee-for-service treatment, the expense may discourage patients without medical insurance from seeking medical treatment. However, there was an overall increase in infection rates. This could be due to both antibiotic resistance occurring at overwhelming rates and the ease of spread of SSTIs by close personal contact, exposure to draining lesions, and inaccurate diagnosis and treatment.
Limitations in this study included the inability to separate first-time visits from repeat visits. A person returning for an unresolved SSTI may have been counted more than one time, and the analysis does not account for patient follow-up. In addition, patients may have been diagnosed with more than one type of SSTI (e.g., cellulitis and abscess) and therefore may have been identified by two or more ICD-9 codes. The category of antibiotics prescribed does not specify the diagnosis for which the drug was prescribed, and an assumption was made that each antibiotic was recorded for the patient presenting for an SSTI during that visit. The CDC database does not have current procedural terminology (CPT) coding for incision and drainage, needle aspiration, or debridement of abscesses and wounds. These interventions are first-line treatments for infections that fluctuate or that have pus that could be drained. There was also no information to determine if the patient's infection was cultured and tested for antibiotic sensitivity.
Further study is needed to determine what percentages of patients experienced incision and drainage, debridement, and needle aspirations and the susceptibility patterns of cultured infections. If possible, it would be beneficial to track the patients' courses of treatment from diagnosis to resolution to estimate duration of treatment. The use of other antibiotics, such as rifampicin as an adjunct therapy and linezolid, should also be analyzed to determine changes in prescription patterns. Examination of reinfection rates would also prove to be useful to determine which patients are at risk for reinfection and to establish which patients may benefit from decolonization of MRSA.
Overall, this study demonstrates that there is an increase in infection rates, and healthcare providers are recognizing patients presenting with SSTIs. Patients are treated according to the increase in CA-MRSA by being prescribed antibiotics that have been proven to be successful against the bacteria.
